幽门螺杆菌ATP酶系统的鉴定与特性以及质子泵抑制剂的作用 - Suppr

Suppr

超能文献

Identification and characterization of an ATPase system of Helicobacter pylori and the effect of proton pump inhibitors.

作者信息

Mauch F, Bode G, Malfertheiner P

出版信息

Am J Gastroenterol. 1993 Oct;88(10):1801-2.

PMID:8213737

Abstract

摘要

相似文献

Identification and characterization of an ATPase system of Helicobacter pylori and the effect of proton pump inhibitors.幽门螺杆菌ATP酶系统的鉴定与特性以及质子泵抑制剂的作用

Am J Gastroenterol. 1993 Oct;88(10):1801-2.

Partial characterization and effect of omeprazole on ATPase activity in Helicobacter pylori by using permeabilized cells.利用透化细胞对奥美拉唑对幽门螺杆菌ATP酶活性的部分特性及影响

Antimicrob Agents Chemother. 1995 Aug;39(8):1717-20. doi: 10.1128/AAC.39.8.1717.

Helicobacter pylori infection and antisecretory efficacy of proton-pump inhibitors in gastroesophageal reflux disease: a liaison dangereuse or an innocent interplay?幽门螺杆菌感染与质子泵抑制剂在胃食管反流病中的抑酸疗效：危险关联还是无害相互作用？

Scand J Gastroenterol. 2006 Oct;41(10):1121-5. doi: 10.1080/00365520600931584.

Structure-activity relationship of 2-[[(2-pyridyl)methyl]thio]-1H- benzimidazoles as anti Helicobacter pylori agents in vitro and evaluation of their in vivo efficacy.2-[[(2-吡啶基)甲基]硫代]-1H-苯并咪唑类化合物作为抗幽门螺杆菌药物的体外构效关系及其体内疗效评价

J Med Chem. 1998 May 21;41(11):1777-88. doi: 10.1021/jm970165r.

Proton pump inhibitors and Helicobacter pylori gastritis: friends or foes?质子泵抑制剂与幽门螺杆菌胃炎：是友还是敌？

Basic Clin Pharmacol Toxicol. 2006 Sep;99(3):187-94. doi: 10.1111/j.1742-7843.2006.pto_478.x.

[Helicobacter pylori increases the antisecretory activity of omeprazole in the parietal cell and the proton pump].

Gastroenterol Clin Biol. 2001 Dec;25(12):1127-8.

[Are proton pump inhibitors superior to H2 receptor antagonists within the scope of H. pylori eradication therapy? Meta analysis of current parallel group comparisons].[在幽门螺杆菌根除治疗范围内，质子泵抑制剂是否优于H2受体拮抗剂？当前平行组比较的荟萃分析]

Z Gastroenterol. 1996 May;34(5):267-72.

Properties and function of the P type ion pumps cloned from Helicobacter pylori.从幽门螺杆菌中克隆的P型离子泵的特性与功能

Acta Physiol Scand Suppl. 1998 Aug;643:123-35.

Should Helicobacter pylori be eradicated before starting long-term proton pump inhibitors?在开始长期使用质子泵抑制剂之前，幽门螺杆菌是否应该根除？

Ital J Gastroenterol Hepatol. 1997 Dec;29(6):569-73.

Review article: Helicobacter pylori and gastro-oesophageal reflux disease.综述文章：幽门螺杆菌与胃食管反流病

Aliment Pharmacol Ther. 2005 Aug;22 Suppl 1:32-40. doi: 10.1111/j.1365-2036.2005.02607.x.

引用本文的文献

The Clinician's Guide to Proton Pump Inhibitor Related Adverse Events.质子泵抑制剂相关不良反应的临床指南。

Drugs. 2019 May;79(7):715-731. doi: 10.1007/s40265-019-01110-3.

The Gastric and Intestinal Microbiome: Role of Proton Pump Inhibitors.胃肠道微生物群：质子泵抑制剂的作用

Curr Gastroenterol Rep. 2017 Aug;19(8):42. doi: 10.1007/s11894-017-0577-6.

Revaprazan, a novel acid pump antagonist, exerts anti-inflammatory action against Helicobacter pylori-induced COX-2 expression by inactivating Akt signaling.雷贝拉唑是一种新型的酸泵拮抗剂，通过失活 Akt 信号通路来发挥抗幽门螺杆菌诱导的 COX-2 表达的抗炎作用。

J Clin Biochem Nutr. 2012 Sep;51(2):77-83. doi: 10.3164/jcbn.11-94. Epub 2012 Jul 20.

Structure-based inhibitors exhibit differential activities against Helicobacter pylori and Escherichia coli undecaprenyl pyrophosphate synthases.基于结构的抑制剂对幽门螺杆菌和大肠杆菌的十一异戊二烯焦磷酸合酶表现出不同的活性。

J Biomed Biotechnol. 2008;2008:841312. doi: 10.1155/2008/841312.

Lansoprazole Novel Effector Sites Revealed by Autoradiography: Relation to Helicobacter pylori, Colon, Esophagus and Others.兰索拉唑的新型作用位点通过放射自显影揭示：与幽门螺杆菌、结肠、食管等的关系。

J Clin Biochem Nutr. 2007 Nov;41(3):154-9. doi: 10.3164/jcbn.2007021.

Novel action of gastric proton pump inhibitor on suppression of Helicobacter pylori induced angiogenesis.胃质子泵抑制剂对抑制幽门螺杆菌诱导的血管生成的新作用。

Gut. 2006 Jan;55(1):26-33. doi: 10.1136/gut.2005.067454. Epub 2005 Aug 26.

Remission of idiopathic thrombocytopenic purpura by eradicating Helicobacter pylori after omeprazole monotherapy.奥美拉唑单药治疗后根除幽门螺杆菌使特发性血小板减少性紫癜缓解

Int J Hematol. 2001 Aug;74(2):237-8. doi: 10.1007/BF02982013.

Inhibitory activities of lansoprazole against respiration in Helicobacter pylori.兰索拉唑对幽门螺杆菌呼吸作用的抑制活性。

Antimicrob Agents Chemother. 2001 May;45(5):1522-7. doi: 10.1128/AAC.45.5.1522-1527.2001.

Basis for the selective antibacterial activity in vitro of proton pump inhibitors against Helicobacter spp.质子泵抑制剂对幽门螺杆菌的体外选择性抗菌活性基础

Antimicrob Agents Chemother. 1997 Aug;41(8):1797-801. doi: 10.1128/AAC.41.8.1797.

Pantoprazole. A review of its pharmacological properties and therapeutic use in acid-related disorders.泮托拉唑。其药理特性及在酸相关性疾病治疗中的应用综述。

Drugs. 1996 Mar;51(3):460-82. doi: 10.2165/00003495-199651030-00012.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验